In summary, many studies in breast cancer and other epithelial cancers, such as NSCLC [116], pancreatic cancer [54], colon cancer [69], and prostate cancer [149], have found that a high expression of periostin in tumor stroma, particularly in CAFs, can be used as a prognostic biomarker [60]. This evidence concerns the gene POSTN and neoplasm.